SPECIAL NOTICE
R -- Intent to Award a Sole Source Contract: on a research project to explore advanced imaging technologies and AI assisted image analysis to facilitate product development and ANDA assessment of complex generics.
- Notice Date
- 8/29/2025 10:03:07 AM
- Notice Type
- Special Notice
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- FDA CENTER FOR DRUG EVALUATION AND RESEARCH Silver Spring MD 20993 USA
- ZIP Code
- 20993
- Solicitation Number
- FDAJOFOC8292025
- Response Due
- 9/11/2025 10:00:00 AM
- Archive Date
- 09/26/2025
- Point of Contact
- Howard S. Yablon
- E-Mail Address
-
howard.yablon@fda.hhs.gov
(howard.yablon@fda.hhs.gov)
- Description
- Justification for Other than Full and Open Competition. See Attachment.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/a86bf7ee18214db2afec6966682a4814/view)
- Place of Performance
- Address: Silver Spring, MD 20993, USA
- Zip Code: 20993
- Country: USA
- Zip Code: 20993
- Record
- SN07572604-F 20250831/250829230043 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |